Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, ...

Small vessel vasculitis is the most common cause of vasculitis in patients with LE and may be secondary to other rheumatic diseases such as rheumatoid arthritis, dermatomyositis, and Sjogren's ...

Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

Biopsies of the left lower extremity lesions were read as septal panniculitis/small vessel vasculitis. During hospitalization, the patient was given high-dose steroids with subsequent improvement ...

In small-vessel vasculitides, ultrasonography assesses pathologies that are secondary to vasculitis. It is not possible to delineate pathogenetic features, but it is useful for staging of the disease.

NS-229 is an investigational selective Janus kinase 1 inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell activation.